These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 181842)
21. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases. Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225 [TBL] [Abstract][Full Text] [Related]
22. Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse. Simon JR; Ghetti B Neurochem Int; 1993 May; 22(5):471-7. PubMed ID: 8485453 [TBL] [Abstract][Full Text] [Related]
23. Effect of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat. Wuerthele SM; Freed WJ; Olson L; Morihisa J; Spoor L; Wyatt RJ; Hoffer BJ Exp Brain Res; 1981; 44(1):1-10. PubMed ID: 7274357 [TBL] [Abstract][Full Text] [Related]
24. Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Rosales MG; Flores G; Hernández S; MartÃnez-Fong D; Aceves J Brain Res; 1994 May; 645(1-2):335-7. PubMed ID: 8062095 [TBL] [Abstract][Full Text] [Related]
25. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics. Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903 [No Abstract] [Full Text] [Related]
26. Dopamine-sensitive adenylate cyclase and cAMP phosphodiesterase in substantia nigra and corpus striatum of rat brain. Traficante LJ; Friedman E; Oleshansky MA; Gershon S Life Sci; 1976 Oct; 19(7):1061-6. PubMed ID: 186677 [No Abstract] [Full Text] [Related]
27. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin. Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027 [TBL] [Abstract][Full Text] [Related]
28. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine. Roger LJ; Breese GR; Morell P Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743 [TBL] [Abstract][Full Text] [Related]
29. Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod. Bergquist F; Shahabi HN; Nissbrandt H Brain Res; 2003 May; 973(1):81-91. PubMed ID: 12729956 [TBL] [Abstract][Full Text] [Related]
31. Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis. Bergquist F; Nissbrandt H Neuroscience; 2003; 120(3):757-64. PubMed ID: 12895515 [TBL] [Abstract][Full Text] [Related]
32. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain. Hungen KV; Roberts S; Hill DF Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721 [TBL] [Abstract][Full Text] [Related]
33. Dendritic release of dopamine in the substantia nigra. Cheramy A; Leviel V; Glowinski J Nature; 1981 Feb; 289(5798):537-42. PubMed ID: 6258083 [TBL] [Abstract][Full Text] [Related]
34. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus. Tonon G; Saiani L; Spano PF; Trabucchi M Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486 [No Abstract] [Full Text] [Related]
35. Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity. Volta M; Viaro R; Trapella C; Marti M; Morari M Exp Neurol; 2011 Mar; 228(1):126-37. PubMed ID: 21215744 [TBL] [Abstract][Full Text] [Related]
36. Activation of the nigrostriatal dopaminergic pathway by injection of cholera enterotoxin into the substantia nigra. Quenzer LF; Galli CL; Neff NH Science; 1977 Jan; 195(4273):78-80. PubMed ID: 831258 [TBL] [Abstract][Full Text] [Related]
37. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra. Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489 [No Abstract] [Full Text] [Related]
38. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Castro SL; Zigmond MJ Brain Res; 2001 May; 901(1-2):47-54. PubMed ID: 11368949 [TBL] [Abstract][Full Text] [Related]
39. Biogenic amine-sensitive adenylate cyclases in primary culture of neuronal or glial cells from mesencephalon. Chneiweiss H; Prochiantz A; Glowinski J; Premont J Brain Res; 1984 Jun; 302(2):363-70. PubMed ID: 6329463 [TBL] [Abstract][Full Text] [Related]
40. The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra. Williams J; Davies JA J Pharm Pharmacol; 1983 Nov; 35(11):734-7. PubMed ID: 6139455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]